Literature DB >> 12481165

Vasoactive intestinal polypeptide and gastrin-releasing peptide attenuate hepatic microvasculatory disturbances following intestinal ischemia and reperfusion.

Ingo Leister1, Ebenzar M Mbachu, Stefan Post, Stefan T Samel, Tomislav Stojanovic, Carsten N Gutt, Heinz Becker, Peter M Markus.   

Abstract

BACKGROUND/AIMS: In addition to the primarily affected small bowel, intestinal ischemia and reperfusion (IIR) also leads to a marked decrease in hepatic microcirculation. The aim was to determine the potentially protective effect of the vasoactive hormones vasoactive intestinal polypeptide (VIP) and gastrin-releasing peptide (GRP) on hepatic microcirculation following IIR.
METHODS: Using a rat model, three animal groups were subjected to 40 min of intestinal ischemia, two of which were infused with either VIP or GRP (n = 12 each). Following reperfusion, hepatic intravital microscopy was performed. Portal venous perfusion, activities of serum glutamate pyruvate transaminase and alkaline phosphatase, mucosal injury in the small intestine and the expression of antioxidant enzymes glutathione peroxidase, copper-zinc-superoxide dismutase (Cu-Zn-SOD), glutathione reductase and catalase (CAT) in the liver were investigated.
RESULTS: Infusion of either VIP or GRP improved hepatic microcirculation and bile flow when compared with the untreated IIR group. VIP and GRP increased portal venous blood flow during reperfusion. VIP reduced the extent of mucosal damage resulting from IIR. GRP caused a decrease in expression of CAT and Cu-Zn-SOD, whereas VIP simply reduced CAT expression.
CONCLUSION: This study indicates that vasoactive hormones may attenuate intestinal and hepatic injuries and circulatory disturbances following IIR. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12481165     DOI: 10.1159/000066761

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  10 in total

1.  Sulforaphane protects liver injury induced by intestinal ischemia reperfusion through Nrf2-ARE pathway.

Authors:  Hai-Dong Zhao; Feng Zhang; Gang Shen; Yu-Bing Li; Ying-Hua Li; Hui-Rong Jing; Ling-Fei Ma; Ji-Hong Yao; Xiao-Feng Tian
Journal:  World J Gastroenterol       Date:  2010-06-28       Impact factor: 5.742

2.  Microcirculation and excretory function of the liver under conditions of carbon dioxide pneumoperitoneum.

Authors:  I Leister; P Schüler; B Vollmar; L Füzesi; E Kahler; H Becker; P M Markus
Journal:  Surg Endosc       Date:  2004-06-23       Impact factor: 4.584

3.  Vasoactive intestinal peptide attenuates liver ischemia/reperfusion injury in mice via the cyclic adenosine monophosphate-protein kinase a pathway.

Authors:  Haofeng Ji; Yu Zhang; Yuanxing Liu; Xiu-Da Shen; Feng Gao; Terry T Nguyen; Ronald W Busuttil; James A Waschek; Jerzy W Kupiec-Weglinski
Journal:  Liver Transpl       Date:  2013-07-26       Impact factor: 5.799

4.  Vasoactive intestinal peptide increases hepatic transduction and reduces innate immune response following administration of helper-dependent Ad.

Authors:  Francesco Vetrini; Nicola Brunetti-Pierri; Donna J Palmer; Terry Bertin; Nathan C Grove; Milton J Finegold; Philip Ng
Journal:  Mol Ther       Date:  2010-05-11       Impact factor: 11.454

5.  Role of endothelium and nitric oxide in modulating in vitro responses of colonic arterial and venous rings to vasodilatory neuropeptides in horses.

Authors:  Rustin M Moore; Steven A Sedrish; Earnestine P Holmes; Catherine E Koch; Changaram S Venugopal
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

6.  Impact of vasoactive intestinal polypeptide and gastrin-releasing peptide on small bowel microcirculation and mucosal injury after hepatic ischemia/reperfusion in rats.

Authors:  Ingo Leister; J Sydow; T Stojanovic; L Füzesi; B Sattler; M Heuser; H Becker; P M Markus
Journal:  Int J Colorectal Dis       Date:  2004-07-27       Impact factor: 2.571

7.  Prophylaxis with carnosol attenuates liver injury induced by intestinal ischemia/reperfusion.

Authors:  Ji-Hong Yao; Xue-Song Zhang; Shu-Sen Zheng; Ying-Hua Li; Li-Ming Wang; Zhen-Zhen Wang; Liang Chu; Xiao-Wei Hu; Ke-Xin Liu; Xiao-Feng Tian
Journal:  World J Gastroenterol       Date:  2009-07-14       Impact factor: 5.742

8.  Modulation of Immune Checkpoints and Graft-versus-Leukemia in Allogeneic Transplants by Antagonizing Vasoactive Intestinal Peptide Signaling.

Authors:  Jian-Ming Li; Christopher T Petersen; Jing-Xia Li; Reema Panjwani; Daniel J Chandra; Cynthia R Giver; Bruce R Blazar; Edmund K Waller
Journal:  Cancer Res       Date:  2016-09-26       Impact factor: 12.701

9.  Ginsenoside Rb1 attenuates intestinal ischemia-reperfusion- induced liver injury by inhibiting NF-kappaB activation.

Authors:  Jin Wang; Lifen Qiao; Yongsheng Li; Guangtian Yang
Journal:  Exp Mol Med       Date:  2008-12-31       Impact factor: 8.718

10.  Modulating the p66shc signaling pathway with protocatechuic acid protects the intestine from ischemia-reperfusion injury and alleviates secondary liver damage.

Authors:  Lingfei Ma; Guangzhi Wang; Zhao Chen; Zhenlu Li; Jihong Yao; Haidong Zhao; Shu Wang; Zhenhai Ma; Hong Chang; Xiaofeng Tian
Journal:  ScientificWorldJournal       Date:  2014-03-16
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.